« Alle Studien

ASTRAL-2 Studie

Comparison of Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks With Sofosbuvir and Ribavirin for 12 Weeks in Adults With Chronic Genotype 2 HCV Infection

Literaturstellen

Im Arzneimittelbrief